Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy.
about
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL KinaseThe role of phenotypic plasticity in the escape of cancer cells from targeted therapy.Roles of Grainyhead-like transcription factors in cancer.Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.Differential expression and clinical significance of epithelial-mesenchymal transition markers among different histological types of triple-negative breast cancer.Molecularly-targeted therapy for the oral cancer stem cells.
P2860
Q54798494-0F290D67-F010-4A99-B697-9F7663C653A4Q54798496-71EF7590-D3EF-496B-9039-DD9A46123151Q54954663-9AFD7DB5-7772-44C5-AB3C-65792CC2E216Q54954665-FE54E321-71C1-4BFC-86F7-8EE25EA2148DQ54954666-722B8A3C-2A31-48F2-BE7F-BB224AEDF70DQ54954670-54EDD25C-32CE-4741-A220-50A32B6304AAQ54954671-F14B8ACB-B071-4217-9B0C-7579AFBA5AA4
P1343
Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Identification of novel pathwa ...... ance to HER2-targeted therapy.
@en
type
label
Identification of novel pathwa ...... ance to HER2-targeted therapy.
@en
prefLabel
Identification of novel pathwa ...... ance to HER2-targeted therapy.
@en
P2093
P2860
P4510
P50
P356
P1433
P1476
Identification of novel pathwa ...... ance to HER2-targeted therapy.
@en
P2093
Asier Unciti-Broceta
Bryan Serrels
Craig Fraser
Helen Creedon
Jozef Balla
Kenneth G MacLeod
Marta Canel
Teresa Klinowska
Valerie G Brunton
Žygimantė Tarnauskaitė
P2860
P304
11539-11552
P356
10.18632/ONCOTARGET.7317
P407
P577
2016-02-11T00:00:00Z